HIV-1 reprograms the migration of macrophages

Blood

Volumn 125, Issue 10, 2015, Pages 1611-1622

  Vérollet, Christel ^a,b   Souriant, Shanti ^a,b   Bonnaud, Emilie ^a,b   Jolicoeur, Paul ^c,d,e   Raynaud Messina, Brigitte ^a,b   Kinnaer, Cassandre ^a,b   Fourquaux, Isabelle ^b   Imle, Andrea ^f   Benichou, Serge ^a,g   Fackler, Oliver T ^f   Poincloux, Renaud ^a,b   Maridonneau Parini, Isabelle ^a,b  

^a CNRS   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f Integrative Virology   (Germany)

^g INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

F ACTIN; HEMATOPOIETIC CELL KINASE; NEF PROTEIN; WISKOTT ALDRICH SYNDROME PROTEIN; HCK PROTEIN, HUMAN; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; WAS PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MOTILITY; CELL STRUCTURE; CONTROLLED STUDY; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MACROPHAGE; MACROPHAGE MIGRATION; MONOCYTE; MOUSE; MYELOPOIESIS; NONHUMAN; NORMAL HUMAN; PHAGOCYTE; PODOSOME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; STEADY STATE; TUMOR ASSOCIATED LEUKOCYTE; ANIMAL; CELL CULTURE; CELL MOTION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMBRANE STRUCTURE; NUCLEAR REPROGRAMMING; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; TUMOR CELL LINE; VIROLOGY;

ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE STRUCTURES; CELL MOVEMENT; CELLS, CULTURED; CELLULAR REPROGRAMMING; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROPHAGES; MICE; MICE, TRANSGENIC; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PROTO-ONCOGENE PROTEINS C-HCK; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 84924986532     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-08-596775     Document Type: Article

References (84)

1. Carter CA, Ehrlich LS. Cell biology of HIV-1 infection of macrophages. Annu Rev Microbiol. 2008;62:425-443.
2. Deneka M, Pelchen-Matthews A, Byland R, Ruiz-Mateos E, Marsh M. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J Cell Biol. 2007;177(2):329-341.
3. Tan J, Sattentau QJ. The HIV-1-containing macrophage compartment: a perfect cellular niche? Trends Microbiol. 2013;21(8):405-412.
4. Orenstein JM. The macrophage in HIV infection. Immunobiology. 2001;204(5):598-602.
5. Raposo G, Moore M, Innes D, et al. Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic. 2002;3(10):718-729.
6. Collman RG, Perno CF, Crowe SM, Stevenson M, Montaner LJ. HIV and cells of macrophage/dendritic lineage and other non-T cell reservoirs: new answers yield new questions. J Leukoc Biol. 2003;74(5):631-634.
7. González-Scarano F, Martín-García J. The neuropathogenesis of AIDS. Nat Rev Immunol. 2005;5(1):69-81.
8. Vérollet C, Zhang YM, Le Cabec V, et al. HIV-1 Nef triggers macrophage fusion in a p61Hck- and protease-dependent manner. J Immunol. 2010;184(12):7030-7039.
9. Allers K, Fehr M, Conrad K, et al. Macrophages accumulate in the gut mucosa of untreated HIV-infected patients. J Infect Dis. 2014;209(5):739-748.
10. Smith PD, Meng G, Salazar-Gonzalez JF, Shaw GM. Macrophage HIV-1 infection and the gastrointestinal tract reservoir. J Leukoc Biol. 2003;74(5):642-649.
11. Xu H, Wang X, Veazey RS. Mucosal immunology of HIV infection. Immunol Rev. 2013;254(1):10-33.
12. Ciborowski P, Gendelman HE. Human immunodeficiency virus-mononuclear phagocyte interactions: emerging avenues of biomarker discovery, modes of viral persistence and disease pathogenesis. Curr HIV Res. 2006;4(3):279-291.
13. Janardhan A, Swigut T, Hill B, Myers MP, Skowronski J. HIV-1 Nef binds the DOCK2-ELMO1 complex to activate rac and inhibit lymphocyte chemotaxis. PLoS Biol. 2004;2(1):E6.
14. Nobile C, Rudnicka D, Hasan M, et al. HIV-1 Nef inhibits ruffles, induces filopodia, and modulates migration of infected lymphocytes. J Virol. 2010;84(5):2282-2293.
15. Park IW, He JJ. HIV-1 Nef-mediated inhibition of T cell migration and its molecular determinants. J Leukoc Biol. 2009;86(5):1171-1178.
16. Stolp B, Imle A, Coelho FM, et al. HIV-1 Nef interferes with T-lymphocyte circulation through confined environments in vivo. Proc Natl Acad Sci USA. 2012;109(45):18541-18546.
17. Stolp B, Reichman-Fried M, Abraham L, et al. HIV-1 Nef interferes with host cell motility by deregulation of Cofilin. Cell Host Microbe. 2009;6(2):174-186.
18. Murooka TT, Deruaz M, Marangoni F, et al. HIV-infected T cells are migratory vehicles for viral dissemination. Nature. 2012;490(7419):283-287.
19. Fackler OT, Kräusslich HG. Interactions of human retroviruses with the host cell cytoskeleton. Curr Opin Microbiol. 2006;9(4):409-415.
20. Foster JL, Garcia JV. HIV-1 Nef: at the crossroads. Retrovirology. 2008;5:84.
21. Laguette N, Benichou S, Basmaciogullari S. Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivity. J Virol. 2009;83(2):1093-1104.
22. Oldridge J, Marsh M. Nef: an adaptor adaptor? Trends Cell Biol. 1998;8(8):302-305.
23. Fackler OT, Murooka TT, Imle A, Mempel TR. Adding new dimensions: towards an integrative understanding of HIV-1 spread. Nat Rev Microbiol. 2014;12(8):563-574.
24. Renkema GH, Manninen A, Mann DA, Harris M, Saksela K. Identification of the Nef-associated kinase as p21-activated kinase 2. Curr Biol. 1999;9(23):1407-1410.
25. Friedl P, Sahai E, Weiss S, Yamada KM. New dimensions in cell migration. Nat Rev Mol Cell Biol. 2012;13(11):743-747.
26. Wiesner C, Le-Cabec V, El Azzouzi K, Maridonneau-Parini I, Linder S. Podosomes in space: macrophage migration and matrix degradation in 2D and 3D settings. Cell Adhes Migr. 2014;8(3):179-191.
27. Friedl P, Weigelin B. Interstitial leukocyte migration and immune function. Nat Immunol. 2008;9(9):960-969.
28. Lämmermann T, Sixt M. Mechanical modes of 'amoeboid' cell migration. Curr Opin Cell Biol. 2009;21(5):636-644.
29. Madsen CD, Sahai E. Cancer dissemination - lessons from leukocytes. Dev Cell. 2010;19(1):13-26.
30. Van Goethem E, Poincloux R, Gauffre F, Maridonneau-Parini I, Le Cabec V. Matrix architecture dictates three-dimensional migration modes of human macrophages: differential involvement of proteases and podosome-like structures. J Immunol. 2010;184(2):1049-1061.
31. Van Goethem E, Guiet R, Balor S, et al. Macrophage podosomes go 3D. Eur J Cell Biol. 2011;90(2-3):224-236.
32. Cougoule C, Le Cabec V, Poincloux R, et al. Three-dimensional migration of macrophages requires Hck for podosome organization and extracellular matrix proteolysis. Blood. 2010;115(7):1444-1452.
33. Park H, Dovas A, Hanna S, et al. Tyrosine phosphorylation of WASP by Hck regulates macrophage function. J Biol Chem. 2014;289(11):7897-7906.
34. Vérollet C, Gallois A, Dacquin R, et al. Hck contributes to bone homeostasis by controlling the recruitment of osteoclast precursors. FASEB J. 2013;27(9):3608-3618.
35. García E, Jones GE, Machesky LM, Antón IM. WIP: WASP-interacting proteins at invadopodia and podosomes. Eur J Cell Biol. 2012;91(11-12):869-877.
36. Cougoule C, Van Goethem E, Le Cabec V, et al. Blood leukocytes and macrophages of various phenotypes have distinct abilities to form podosomes and to migrate in 3D environments. Eur J Cell Biol. 2012;91(11-12):938-949.
37. Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, Jolicoeur P. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell. 1998;95(2):163-175.
38. Hanna Z, Priceputu E, Chrobak P, et al. Selective expression of human immunodeficiency virus Nef in specific immune cell populations of transgenic mice is associated with distinct AIDS-like phenotypes. J Virol. 2009;83(19):9743-9758.
39. Labernadie A, Thibault C, Vieu C, Maridonneau-Parini I, Charrière GM. Dynamics of podosome stiffness revealed by atomic force microscopy. Proc Natl Acad Sci USA. 2010;107(49):21016-21021.
40. Troegeler A, Lastrucci C, Duval C, et al. An efficient siRNA-mediated gene silencing in primary human monocytes, dendritic cells and macrophages. Immunol Cell Biol. 2014;92(8):699-708.
41. Gendelman HE, Orenstein JM, Martin MA, et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med. 1988;167(4):1428-1441.
42. Mazzolini J, Herit F, Bouchet J, Benmerah A, Benichou S, Niedergang F. Inhibition of phagocytosis in HIV-1-infected macrophages relies on Nef-dependent alteration of focal delivery of recycling compartments. Blood. 2010;115(21):4226-4236.
43. + T cells across an in vitro blood-brain barrier model. Virology. 2014;454-455:128-138.
44. Steckbeck JD, Orlov I, Chow A, et al. Kinetic rates of antibody binding correlate with neutralization sensitivity of variant simian immunodeficiency virus strains. J Virol. 2005;79(19):12311-12320.
45. Ling H, Sylvestre JR, Jolicoeur P. Cyclin D1-dependent induction of luminal inflammatory breast tumors by activated notch3. Cancer Res. 2013;73(19):5963-5973.
46. Chrobak P, Simard MC, Bouchard N, et al. HIV-1 Nef disrupts maturation of CD4+ T cells through CD4/Lck modulation. J Immunol. 2010;185(7):3948-3959.
47. Pan X, Rudolph JM, Abraham L, et al. HIV-1 Nef compensates for disorganization of the immunological synapse by inducing trans-Golgi network-associated Lck signaling. Blood. 2012;119(3):786-797.
48. Ahsan MH, Gill AF, Alvarez X, Lackner AA, Veazey RS. Kinetics of liver macrophages (Kupffer cells) in SIV-infected macaques. Virology. 2013;446(1-2):77-85.
49. Stephens EB, Tian C, Li Z, Narayan O, Gattone VH 2nd. Rhesus macaques infected with macrophage-tropic simian immunodeficiency virus (SIVmacR71/17E) exhibit extensive focal segmental and global glomerulosclerosis. J Virol. 1998;72(11):8820-8832.
50. Franklin RA, Liao W, Sarkar A, et al. The cellular and molecular origin of tumor-associated macrophages. Science. 2014;344(6186):921-925.
51. Cortesio CL, Wernimont SA, Kastner DL, Cooper KM, Huttenlocher A. Impaired podosome formation and invasive migration of macrophages from patients with a PSTPIP1 mutation and PAPA syndrome. Arthritis Rheum. 2010;62(8):2556-2558.
52. Wiesner C, El Azzouzi K, Linder S. A specific subset of RabGTPases controls cell surface exposure of MT1-MMP, extracellular matrix degradation and three-dimensional invasion of macrophages. J Cell Sci. 2013;126(Pt 13):2820-2833.
53. Maridonneau-Parini I. Control of macrophage 3D migration, a therapeutic challenge to limit tissue infiltration. Immunol Rev. 2014.
54. Labernadie A, Bouissou A, Delobelle P, et al. Protrusion force microscopy reveals oscillatory force generation and mechanosensing activity of human macrophage podosomes. Nat Commun. 2014;5:5343.
55. Linder S. The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol. 2007;17(3):107-117.
56. van den Dries K, Meddens MB, de Keijzer S, et al. Interplay between myosin IIA-mediated contractility and actin network integrity orchestrates podosome composition and oscillations. Nat Commun. 2013;4:1412.
57. Poincloux R, Al Saati T, Maridonneau-Parini I, Le Cabec V. The oncogenic activity of the Src family kinase Hck requires the cooperative action of the plasma membrane- and lysosome-associated isoforms. Eur J Cancer. 2009;45(3):321-327.
58. Guiet R, Vérollet C, Lamsoul I, et al. Macrophage mesenchymal migration requires podosome stabilization by filamin A. J Biol Chem. 2012;287(16):13051-13062.
59. Maridonneau-Parini I. Podosomes are disrupted in PAPA syndrome. Blood. 2014;123(17):2597-2599.
60. Starnes TW, Bennin DA, Bing X, et al. The F-BAR protein PSTPIP1 controls extracellular matrix degradation and filopodia formation in macrophages. Blood. 2014;123(17):2703-2714.
61. Jevnikar Z, Mirković B, Fonović UP, Zidar N, Švajger U, Kos J. Three-dimensional invasion of macrophages is mediated by cysteine cathepsins in protrusive podosomes. Eur J Immunol. 2012;42(12):3429-3441.
62. Destaing O, Sanjay A, Itzstein C, et al. The tyrosine kinase activity of c-Src regulates actin dynamics and organization of podosomes in osteoclasts. Mol Biol Cell. 2008;19(1):394-404.
63. Bouchet J, Basmaciogullari SE, Chrobak P, et al. Inhibition of the Nef regulatory protein of HIV-1 by a single-domain antibody. Blood. 2011;117(13):3559-3568.
64. Bouchet J, Hérate C, Guenzel CA, et al. Single-domain antibody-SH3 fusions for efficient neutralization of HIV-1 Nef functions. J Virol. 2012;86(9):4856-4867.
65. Moarefi I, LaFevre-Bernt M, Sicheri F, et al. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature. 1997;385(6617):650-653.
66. Briggs SD, Lerner EC, Smithgall TE. Affinity of Src family kinase SH3 domains for HIV Nef in vitro does not predict kinase activation by Nef in vivo. Biochemistry. 2000;39(3):489-495.
67. Saksela K. Interactions of the HIV/SIV pathogenicity factor Nef with SH3 domain-containing host cell proteins. Curr HIV Res. 2011;9(7):531-542.
68. Komuro I, Sunazuka T, Akagawa KS, Yokota Y, Iwamoto A, Omura S. Erythromycin derivatives inhibit HIV-1 replication in macrophages through modulation of MAPK activity to induce small isoforms of C/EBPbeta. Proc Natl Acad Sci USA. 2008;105(34):12509-12514.
69. Suzu S, Harada H, Matsumoto T, Okada S. HIV-1 Nef interferes with M-CSF receptor signaling through Hck activation and inhibits M-CSF bioactivities. Blood. 2005;105(8):3230-3237.
70. Tintori C, Laurenzana I, La Rocca F, et al. Identification of Hck inhibitors as hits for the development of antileukemia and anti-HIV agents. ChemMedChem. 2013;8(8):1353-1360.
71. Tokunaga K, Kiyokawa E, Nakaya M, et al. Inhibition of human immunodeficiency virus type 1 virion entry by dominant-negative Hck. J Virol. 1998;72(7):6257-6259.
72. Dovas A, Gevrey JC, Grossi A, Park H, Abou-Kheir W, Cox D. Regulation of podosome dynamics by WASp phosphorylation: implication in matrix degradation and chemotaxis in macrophages. J Cell Sci. 2009;122(Pt 21):3873-3882.
73. Helming L, Gordon S. Molecular mediators of macrophage fusion. Trends Cell Biol. 2009;19(10):514-522.
74. Stolp B, Abraham L, Rudolph JM, Fackler OT. Lentiviral Nef proteins utilize PAK2-mediated deregulation of cofilin as a general strategy to interfere with actin remodeling. J Virol. 2010;84(8):3935-3948.
75. Thoulouze MI, Sol-Foulon N, Blanchet F, Dautry-Varsat A, Schwartz O, Alcover A. Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse. Immunity. 2006;24(5):547-561.
76. Xu W, Santini PA, Sullivan JS, et al. HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nat Immunol. 2009;10(9):1008-1017.
77. Lämmermann T, Germain RN. The multiple faces of leukocyte interstitial migration. Semin Immunopathol. 2014;36(2):227-251.
78. Coleman SH, Van Damme N, Day JR, et al. Leucine-specific, functional interactions between human immunodeficiency virus type 1 Nef and adaptor protein complexes. J Virol. 2005;79(4):2066-2078.
79. Cougoule C, Carréno S, Castandet J, et al. Activation of the lysosome-associated p61Hck isoform triggers the biogenesis of podosomes. Traffic. 2005;6(8):682-694.
80. Wiesner C, Faix J, Himmel M, Bentzien F, Linder S. KIF5B and KIF3A/KIF3B kinesins drive MT1-MMP surface exposure, CD44 shedding, and extracellular matrix degradation in primary macrophages. Blood. 2010;116(9):1559-1569.
81. Levental KR, Yu H, Kass L, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139(5):891-906.
82. Paszek MJ, Zahir N, Johnson KR, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005;8(3):241-254.
83. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39-51.
84. Haller C, Rauch S, Michel N, et al. The HIV-1 pathogenicity factor Nef interferes with maturation of stimulatory T-lymphocyte contacts by modulation of N-Wasp activity. J Biol Chem. 2006;281(28):19618-19630.